Medical balloon manufacturing market to reach $1.21 billion by 2030

The global medical balloon manufacturing market is projected to grow from $0.97 billion in 2026 to $1.21 billion by 2030, driven by rising demand for minimally invasive procedures and catheter-based treatments. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Medical balloons are a core component in catheter-based treatments, including angioplasty and stent placement. - Growing use of minimally invasive procedures is expanding demand for precision balloon manufacturing. - Rising cardiovascular disease rates are increasing the need for devices that can restore blood flow without open surgery.

What happened: - The Business Research Company projected the global medical balloon manufacturing market will rise from $0.97 billion in 2026 to $1.21 billion by 2030. - The market is expected to grow at a 5.7% compound annual growth rate over the forecast period. - The company said the sector reached $0.91 billion in 2025 and is expected to climb to $0.97 billion in 2026, a 6.0% CAGR increase in the historical period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes a free sample and the full market report.

The details: - Medical balloon manufacturing uses precision fabrication of ultra-thin, expandable balloons for catheter-based medical devices. - The process depends on polymer processing, forming and assembly techniques. - Manufacturers target exact balloon dimensions, optimal wall thickness, flexibility and durability under pressure. - The products are designed to deliver consistent expansion and adaptability during minimally invasive procedures. - The market’s historical growth has been driven by wider adoption of minimally invasive procedures, expanding use of catheter-based devices and rising demand for angioplasty and dilatation balloons. - The sector is also benefiting from demand for precise and dependable balloon performance in clinical settings. - The forecast period is expected to be supported by demand for next-generation specialty balloons, advances in polymer materials and a shift toward ultra-thin balloon walls. - Automation in balloon manufacturing is gaining traction. - Interest is rising in high-pressure and high-compliance balloon designs. - Emerging trends include ultra-thin balloon structures, advanced polymer forming methods, targeted dimensional control and highly flexible, conformable balloon designs.

Between the lines: - The market forecast points to a shift from basic balloon production toward higher-performance, more specialized products. - Precision manufacturing is becoming more important as devices are asked to perform in tighter spaces and under stricter clinical requirements. - Cardiovascular disease trends suggest steady downstream demand for interventional devices, especially as patient populations age. - The American Heart Association projected in February 2026 that 6 in 10 U.S. adults will have cardiovascular disease by 2050. - The same projection said heart valve disease cases are expected to double by 2040 and triple by 2060. - Those long-range health trends support continued demand for catheter-based treatment technologies.

What's next: - Manufacturers are likely to invest more in advanced polymer forming, dimensional control and automation. - The fastest growth is likely to come from Asia-Pacific as regional demand and production capabilities expand. - Specialty balloon designs for high-pressure and high-compliance use cases may become a bigger share of the market. - The company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, and updated graphics and tables.

The bottom line: - Medical balloon manufacturing is moving from a niche supporting role to a more technologically demanding segment tied closely to the growth of minimally invasive cardiovascular care.